Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Anaes SAQsMalignant hyperthermia

Anaes SAQs · Malignant hyperthermia

Recognising and managing the malignant hyperthermia crisis

The canonical MH SAQ — the sentinel ETCO2 (not the fever), the crisis bundle (stop triggers, hyperventilate, dantrolene, cool, treat hyperkalaemia), and the discipline of giving dantrolene early. Built on the EMHG 2024 and MHAUS guidelines.

10 marks10 min2 min readVerification in progress

Target exams

ANZCAFRCAABAEDAIC
On this page
Study tools

Target exams

ANZCAFRCAABAEDAIC
Prompt
Twenty minutes after induction of anaesthesia with sevoflurane for an elective procedure, the end-tidal carbon dioxide rises to 8 kPa despite an unchanged minute volume, the heart rate climbs, and the patient is becoming hot. Outline your diagnosis and immediate management.

Question

Twenty minutes after induction of anaesthesia with sevoflurane for an elective procedure, the end-tidal carbon dioxide rises to 8 kPa despite an unchanged minute volume, the heart rate climbs, and the patient is becoming hot. Outline your diagnosis and immediate management.[9]

Anaesthesia Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Anaesthesia fellowship library.

Sign in to continueSee pricing
References4ShowHide
  1. [8]Glahn KPE, Girard T, Hellblom A, et al. Recognition and management of a malignant hyperthermia crisis: updated 2024 guideline from the European Malignant Hyperthermia Group. British Journal of Anaesthesia, 2025.PMID 39482150
  2. [2]Larach MG, Gronert GA, Allen GC, Brandom BW, Lehman EB. Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006. Anesthesia & Analgesia, 2010.PMID 20081135
  3. [7]Litman RS, Smith VI, Larach MG, et al. Consensus Statement of the MHAUS on Unresolved Clinical Questions Concerning the Management of Patients With Malignant Hyperthermia. Anesthesia & Analgesia, 2019.PMID 30768455
  4. [9]Bersten AD, Soni N (eds) Oh's Intensive Care Manual. 8th edition, Elsevier, 2018.
Anaesthesia Pro

$29/ monthor $279 / year

The complete Anaesthesia library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousInvestigation of malignant hyperthermia susceptibilityMalignant hyperthermiaNextThe pathophysiology of malignant hyperthermiaMalignant hyperthermia